Rafeal Pharmaceuticals

The quest for efficacy in pancreatic cancer
EP Vantage
Thu, 11/11/21 - 10:53 am
pancreatic cancer
Novartis
FibroGen
Tyme Technologies
Erytech
Rafeal Pharmaceuticals
Rafael Pharmaceuticals’ Cancer Metabolism Drug Fails Phase III Assessment
BioSpace
Fri, 10/29/21 - 10:59 am
Rafeal Pharmaceuticals
clinical trials
CPI-613
devimistat
cancer